| International exercise recommendations in older adults (ICFSR): expert consensus guidelines M Izquierdo, RA Merchant, JE Morley, SD Anker, I Aprahamian, H Arai, ... The journal of nutrition, health & aging 25 (7), 824-853, 2021 | 984 | 2021 |
| International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management E Dent, JE Morley, AJ Cruz-Jentoft, H Arai, SB Kritchevsky, J Guralnik, ... The Journal of nutrition, health and aging 22 (10), 1148-1161, 2018 | 980 | 2018 |
| Physical frailty: ICFSR international clinical practice guidelines for identification and management E Dent, JE Morley, AJ Cruz-Jentoft, L Woodhouse, L Rodríguez-Mañas, ... The journal of nutrition, health & aging 23, 771-787, 2019 | 880 | 2019 |
| Frailty as a predictor of cognitive disorders: a systematic review and meta-analysis MK Borges, M Canevelli, M Cesari, I Aprahamian Frontiers in medicine 6, 26, 2019 | 184 | 2019 |
| Screening for frailty with the FRAIL scale: a comparison with the phenotype criteria I Aprahamian, NO de Castro Cezar, R Izbicki, SM Lin, DLV Paulo, ... Journal of the American Medical Directors Association 18 (7), 592-596, 2017 | 164 | 2017 |
| The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous … I Aprahamian, JE Martinelli, AL Neri, MS Yassuda International psychogeriatrics 22 (1), 64-71, 2010 | 153 | 2010 |
| Cerebrospinal fluid biomarkers in Alzheimer's disease: Diagnostic accuracy and prediction of dementia OV Forlenza, M Radanovic, LL Talib, I Aprahamian, BS Diniz, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 1 (4 …, 2015 | 150 | 2015 |
| Doença de Alzheimer: revisão da epidemiologia e diagnóstico I Aprahamian, JE Martinelli, MS Yassuda Rev Bras Clin Med 7 (6), 27-35, 2009 | 149 | 2009 |
| Effects of a multidisciplinar cognitive rehabilitation program for patients with mild Alzheimer's disease LF Viola, PV Nunes, MS Yassuda, I Aprahamian, FS Santos, GD Santos, ... Clinics 66, 1395-1400, 2011 | 143 | 2011 |
| Screening for and managing the person with frailty in primary care: ICFSR consensus guidelines JG Ruiz, E Dent, JE Morley, RA Merchant, J Beilby, J Beard, C Tripathy, ... The journal of nutrition, health & aging 24, 920-927, 2020 | 138 | 2020 |
| The Clock Drawing Test A review of its accuracy in screening for dementia I Aprahamian, JE Martinelli, AL Neri, MS Yassuda Dementia & neuropsychologia 3 (2), 74-80, 2009 | 133 | 2009 |
| Hypertension and frailty in older adults I Aprahamian, E Sassaki, MF Dos Santos, R Izbicki, RC Pulgrossi, ... The Journal of Clinical Hypertension 20 (1), 186-192, 2018 | 125 | 2018 |
| Dementia in Latin America: paving the way toward a regional action plan MA Parra, S Baez, L Sedeño, C Gonzalez Campo, H Santamaría‐García, ... Alzheimer's & Dementia 17 (2), 295-313, 2021 | 114 | 2021 |
| New treatment strategies for Alzheimer's disease: is there a hope? I Aprahamian, F Stella, OV Forlenza Indian Journal of Medical Research 138 (4), 449-460, 2013 | 113 | 2013 |
| Blood brain-derived neurotrophic factor (BDNF) and major depression: do we have a translational perspective? B Arosio, FR Guerini, RCO Voshaar, I Aprahamian Frontiers in behavioral neuroscience 15, 626906, 2021 | 105 | 2021 |
| Eye movement analysis and cognitive processing: detecting indicators of conversion to Alzheimer’s disease MLGF Pereira, MZA Camargo, I Aprahamian, OV Forlenza Neuropsychiatric disease and treatment, 1273-1285, 2014 | 96 | 2014 |
| White matter abnormalities associated with Alzheimer’s disease and mild cognitive impairment: a critical review of MRI studies M Radanovic, FRS Pereira, F Stella, I Aprahamian, LK Ferreira, ... Expert review of neurotherapeutics 13 (5), 483-493, 2013 | 94 | 2013 |
| Sarcopenia is associated with cognitive impairment in older adults: a systematic review and meta-analysis GC Cipolli, MS Yassuda, I Aprahamian The Journal of nutrition, health and aging 23 (6), 525-531, 2019 | 93 | 2019 |
| A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease? JF Cecato, JE Martinelli, R Izbicki, MS Yassuda, I Aprahamian International psychogeriatrics 28 (5), 825-832, 2016 | 91 | 2016 |
| Long-term, low-dose lithium treatment does not impair renal function in the elderly: a 2-year randomized, placebo-controlled trial followed by single-blind extension I Aprahamian, FS Santos, B dos Santos, L Talib, BS Diniz, M Radanovic, ... The Journal of clinical psychiatry 75 (7), 10682, 2014 | 86 | 2014 |
